KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teradyne (TER) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Teradyne (TER) over the last 17 years, with Q3 2025 value amounting to $272.7 million.

  • Teradyne's Cash & Equivalents fell 4653.32% to $272.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $272.7 million, marking a year-over-year decrease of 4653.32%. This contributed to the annual value of $553.4 million for FY2024, which is 2695.68% down from last year.
  • Per Teradyne's latest filing, its Cash & Equivalents stood at $272.7 million for Q3 2025, which was down 4653.32% from $339.3 million recorded in Q2 2025.
  • In the past 5 years, Teradyne's Cash & Equivalents registered a high of $1.1 billion during Q4 2021, and its lowest value of $272.7 million during Q3 2025.
  • In the last 5 years, Teradyne's Cash & Equivalents had a median value of $649.2 million in 2023 and averaged $676.7 million.
  • As far as peak fluctuations go, Teradyne's Cash & Equivalents soared by 4004.34% in 2021, and later crashed by 4653.32% in 2025.
  • Over the past 5 years, Teradyne's Cash & Equivalents (Quarter) stood at $1.1 billion in 2021, then decreased by 23.83% to $854.8 million in 2022, then fell by 11.37% to $757.6 million in 2023, then dropped by 26.96% to $553.4 million in 2024, then plummeted by 50.72% to $272.7 million in 2025.
  • Its Cash & Equivalents stands at $272.7 million for Q3 2025, versus $339.3 million for Q2 2025 and $475.6 million for Q1 2025.